Cutler Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-57
Closed – – 5388
2022
Q3
$0 Sell
57
-92
-62% -$1.76K ﹤0.01% 5641
2022
Q2
$2K Hold
149
– – ﹤0.01% 4410
2022
Q1
$5K Hold
149
– – ﹤0.01% 4195
2021
Q4
$5K Hold
149
– – ﹤0.01% 4246
2021
Q3
$11K Sell
149
-129
-46% -$9.16K ﹤0.01% 3880
2021
Q2
$24K Buy
278
+243
+694% +$23.1K ﹤0.01% 3150
2021
Q1
$3K Hold
35
– – ﹤0.01% 4792
2020
Q4
$1K Hold
35
– – ﹤0.01% 4633
2020
Q3
$1K Hold
35
– – ﹤0.01% 4500
2020
Q2
$2K Hold
35
– – ﹤0.01% 3876
2020
Q1
$1K Hold
35
– – ﹤0.01% 3841
2019
Q4
$3K Hold
35
– – ﹤0.01% 3352
2019
Q3
$3K Hold
35
– – ﹤0.01% 3385
2019
Q2
$10K Buy
35
+4
+13% +$1.41K ﹤0.01% 2704
2019
Q1
$14K Buy
31
+30
+3,000% +$11.7K ﹤0.01% 2298
2018
Q4
$0 Buy
+1
New +$239 ﹤0.01% 4707
2018
Q3
– Sell
-9
Closed -$1K – 4811
2018
Q2
$1K Hold
9
– – ﹤0.01% 3995
2018
Q1
$1K Buy
9
+4
+80% +$783 ﹤0.01% 4210
2017
Q4
$1K Sell
5
-17
-77% -$3.54K ﹤0.01% 4634
2017
Q3
$4K Sell
22
-4
-15% -$736 ﹤0.01% 4658
2017
Q2
$2K Sell
26
-89
-77% -$14.1K ﹤0.01% 5649
2017
Q1
$34K Sell
115
-77
-40% -$22.7K ﹤0.01% 2777
2016
Q4
$69K Buy
192
+189
+6,300% +$70.4K ﹤0.01% 2252
2016
Q3
$1K Buy
+3
New +$1.05K ﹤0.01% 6353

Other funds holding CSCI

Cutler Group's CSCI Position: Q4 2022 in Review

Cutler Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2022, closing a stake of 57 shares.

Cutler Group first reported a position in CSCI in Q3 2016 and held it in 24 quarters. The position peaked at $69K in Q4 2016. 13 funds tracked by Wall St. Rank hold CSCI as of Q4 2022.

  • Cutler Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 57 COSCIENS Biopharma Inc. Common Stock shares in Q4 2022.
  • Cutler Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2016 and held it in 24 quarters.
  • Cutler Group's COSCIENS Biopharma Inc. Common Stock position peaked at $69K in Q4 2016.
  • 13 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.